BioDlink International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 4.200
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 3.25 billion as of February 13, 2026. Its market cap has increased by 133.33% in one year.
Market Cap
3.25B
Enterprise Value
3.26B
Revenue
1.17B
Ranking
n/a
PE Ratio
407.99
Stock Price
4.20
Market Cap Chart
Since November 8, 2019, HKG:1875's market cap has decreased from 3.57B to 3.25B, a decrease of -9.04%. That is a compound annual growth rate of -1.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.25B | 68.00% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 4.79B |
| TYK Medicines | 4.78B |
| Beijing Luzhu Biotechnology | 4.56B |
| Qyuns Therapeutics | 4.45B |
| AIM Vaccine | 3.77B |
| Medtide | 3.43B |
| Jiangsu Recbio Technology | 3.05B |
| Clover Biopharmaceuticals | 2.89B |